Pediatric AIS · CLINICAL

Pediatric arterial ischaemic stroke: monitoring

Childhood AIS and sinovenous thrombosis: diagnosis is harder, time-windows are longer than adults but still tight, and multimodal neuromonitoring (TCD, NIRS, cEEG, NPi, ONSD) has a role in detecting evolution and post-recanalisation surveillance.

ClinicalBedsidePediatricNon-invasiveValidated
CLast reviewed 2026-05-1719-min read

1. Bedside vignettes: why this matters in the PICU

Vignette A. The 8-year-old with sudden right-sided weakness

An 8-year-old presents to the ED 2 hours after sudden onset right-arm weakness and dysarthria. PedNIHSS 12. Non-contrast CT excludes haemorrhage; CT angio shows left M1 occlusion. The pediatric stroke team is activated. The decision to pursue IV-tPA is made in conjunction with the pediatric neurology and stroke service; the decision to also consider mechanical thrombectomy is made jointly with interventional radiology. During the post-arrival workup, the team begins continuous bedside TCD over the right MCA (the unaffected side, as a global haemodynamic monitor), pulse oximetry NIRS over the at-risk hemisphere, and prepares cEEG for the post-recanalisation window. After successful MT with TICI 2b at 4.5 h, post-procedure rSO2 over the recanalised hemisphere rises from 52% to 78% within minutes (hyperperfusion). The team lowers MAP by 15% with a careful esmolol infusion to prevent hyperperfusion bleed; rSO2 settles to 68%; the child does well.

Vignette B. The 18-month-old after cardiac surgery, the silent stroke

An 18-month-old is on day 3 after a complex cardiac repair (Norwood stage 1). NIRS over the right cerebral cortex has been trending down over the last 6 hours from 68% to 51%, despite stable systemic haemodynamics. The bedside aEEG shows new asymmetry: the right hemisphere amplitude has fallen 30%. Pupillary exam is symmetric. The team escalates: head CT shows a new right MCA infarct, presumed cardio-embolic from the post-operative state. Anticoagulation is started after multidisciplinary input; continuous NIRS and cEEG remain in place to monitor for malignant oedema in the days ahead. In a non-verbal, sedated post-cardiac-surgery infant, the bedside MNM signals (asymmetric NIRS and aEEG) were the only early markers of the stroke.

Vignette C. The 12-year-old with sickle cell disease and abnormal STOP TCD

A 12-year-old with HbSS sickle cell disease is in the annual screening clinic. The STOP-protocol TCD shows TAMMV 215 cm/s in the right MCA (abnormal: ≥ 200 cm/s). The child is asymptomatic. Per the STOP-1 trial, chronic monthly transfusion is initiated to reduce stroke risk from 10% per year (untreated) to 1% per year (transfused). The TCD is repeated in 6 weeks to confirm trend and again at 6 months to assess transfusion response. This is the only modality on this page where a TCD number triggers a multi-year therapy in an asymptomatic child.


2. What pediatric AIS monitoring is, and what it is not

Pediatric AIS is a focal arterial occlusion in a child causing acute neurological deficit. It is distinct from:

  • Cerebral sinovenous thrombosis (CSVT): venous occlusion presenting with headache, seizures, raised ICP, often more insidious onset.
  • Haemorrhagic stroke: intracerebral or subarachnoid bleed; diagnostic imaging and management entirely different.
  • Stroke mimics: post-ictal Todd's paresis, complex migraine, conversion disorder, metabolic / encephalopathic syndromes, brain tumours.

The diagnostic burden in children is delayed recognition, not difficult imaging. Children with focal deficits often present several hours late, are misdiagnosed as post-ictal or migrainous, and miss the time window for thrombolysis. The 2019 AHA pediatric stroke guidelines emphasise rapid imaging (MRI with diffusion + MR angiography preferred; CT + CT angio acceptable when MRI is not immediately available) within 6 hours of presentation.

Multimodal monitoring is supportive, not diagnostic. No combination of TCD, NIRS, NPi, ONSD, or cEEG diagnoses stroke. They:

  1. Detect early evolution: a falling NIRS rSO2 unilaterally in a sedated child is the bedside signal of a new ischaemic insult.
  2. Track peri-interventional: continuous TCD during MT detects re-occlusion or hyperperfusion.
  3. Monitor post-recanalisation: NIRS, cEEG, NPi, ONSD all track the evolving oedema and any haemorrhagic transformation.
  4. Inform secondary prevention: TCD STOP screening in SCD; serial TCD in moyamoya.
Clinical pearl

Time matters in pediatric stroke, but the window is wider and less validated than adult. The 2019 AHA pediatric guideline supports IV-tPA in selected children with NIHSS ≥ 6 within 4.5 h of onset, and MT for proximal large-vessel occlusion within 24 h. The decision is multidisciplinary and centre-experience-dependent; pediatric thrombectomy outcomes (Sun 2020, Save ChildS, ESCAPE-CL) are emerging but evidence is C-level.

In children

Pediatric AIS aetiology is heterogeneous. Arteriopathy (transient cerebral arteriopathy, post-VZV arteriopathy, focal cerebral arteriopathy) is the leading single cause; cardio-embolism (CHD, post-op cardiac), prothrombotic states (lupus, antiphospholipid syndrome, factor V Leiden), trauma (dissection), and sickle cell disease account for the remainder. Aetiological workup drives secondary prevention and is parallel to acute monitoring.


3. Anatomy of pediatric stroke and the relevant monitors

Fig. 1
PEDIATRIC AIS PATHWAYdoor to imaging, candidacy, then post-recanalisation monitoringDoor to imaging (<=60 min)MRI + MRA preferred; CT + CTA if MRI delayedConfirmed AISIV-tPA candidacyNIHSS >=6 · within 4.5 h · no haemorrhageThrombectomy candidacyproximal LVO · age >=2-6 (most centres) ·within 24 h · favourable imagingPost-recanalisation MNMTCD (contralateral MCA) · NIRS (at-risk hemisphere) · cEEG · NPi · BPcontrolDays to weeksserial imaging · secondary prevention · rehabilitationMNM-Edu schematic · AHA-aligned pediatric AIS pathway
Pediatric AIS pathway. Door-to-imaging within 60 min: MRI + MRA preferred; CT + CT angio acceptable when MRI is delayed. Confirmed AIS: candidacy for IV-tPA (NIHSS ≥ 6, within 4.5 h, no haemorrhage), candidacy for mechanical thrombectomy (proximal large-vessel occlusion, age ≥ 2 to 6 in most centres, within 24 h with favourable imaging). Post-recanalisation: continuous bedside MNM (TCD over the contralateral MCA, NIRS over the at-risk hemisphere, cEEG, NPi, BP control). Days to weeks: serial imaging, secondary prevention, rehabilitation.
MNM-Edu, original schematic.

The relevant arterial anatomy:

  • Anterior circulation: ICA → M1-MCA, A1-ACA. The vast majority of large-vessel pediatric AIS.
  • Posterior circulation: vertebral arteries → basilar → P1-PCA. Less common; often missed because exam findings are non-localising.
  • Circle of Willis collaterals: ACOM and PCOM are the natural bypass routes; collateral status determines penumbra size and prognosis.
  • Moyamoya disease: progressive bilateral terminal ICA / M1 stenosis with leptomeningeal "puff of smoke" collaterals; carries a high recurrent stroke risk and is monitored serially with TCD and clinical exam.

Where to place each monitor.

MonitorStandard placementWhy
TCD MCABoth temporal windowsBilateral monitoring; contralateral as reference
NIRSBilateral frontal-cortex pads (right and left)Detect asymmetric desaturation
cEEGFull 10-20 montageHemispheric asymmetry, seizure burden
NPiBoth eyesCatches CN III lesion; trend
ONSDBoth eyesDetects raised ICP from malignant oedema
ICP (selected)Right or contralateral cortexOnly if malignant oedema with surgical consideration

4. The signal: what each modality tells you peri-stroke

4.1 Bedside TCD

In the post-recanalisation period, continuous bedside TCD over both MCAs provides three pieces of information:

  1. Reocclusion detection: a sudden fall in MFV in the recanalised vessel signals re-thrombosis.
  2. Hyperperfusion detection: a rise in MFV on the recanalised side relative to baseline or to contralateral (often > 30%) is the bedside signal of hyperperfusion.
  3. Embolic monitoring: high-intensity transient signals (HITS) on the TCD spectrum indicate microemboli passing the insonated vessel.

4.2 NIRS

NIRS rSO2 over the at-risk hemisphere falls with acute ischaemia and rises (often sharply) after recanalisation. The "post-recanalisation rSO2 overshoot" is the bedside hyperperfusion signal. Asymmetric rSO2 (Δ > 10 to 15%) is the bedside detector of evolving stroke in a sedated child whose clinical exam is uninformative.

4.3 cEEG / qEEG

After acute stroke, the affected hemisphere shows slowing and reduced fast activity; the qEEG ADR drops; asymmetry rises. In the days after stroke, electrographic seizures (often non-convulsive) occur in 5 to 15% of pediatric AIS, especially with cortical infarcts. cEEG is the surveillance tool.

4.4 NPi

Catches evolving malignant oedema with CN III compression earlier than the pen-torch. A new asymmetry > 0.7 or a falling NPi in the days post-stroke triggers urgent imaging and consideration of decompressive surgery.

4.5 ONSD

Distends with rising ICP from malignant oedema. Age-banded cut-offs apply (~4.5 mm in 1 to 15 y). Serial ONSD over the post-stroke days is one of the bedside triage signals for decompressive surgery consideration.


5. The numbers: what to record peri-stroke

VariableSourceWhat it tells you
PedNIHSSClinical examStroke severity; trajectory
TCD MCA MFV, PI, LRBilateral TCDReocclusion, hyperperfusion, vasospasm
NIRS rSO2 (both sides)NIRSTissue oxygenation; asymmetry
cEEG / qEEG asymmetry indexcEEGHemispheric injury
NPi (both eyes)PupillometerBrainstem / CN III status
ONSD (both eyes)Bedside ultrasoundSurrogate for raised ICP
MAP and CPP targetArterial lineBP management peri-recanalisation
Serum glucoseBlood gasAvoid hyperglycaemia in acute ischaemia
TemperatureCoreAvoid hyperthermia

The peri-recanalisation bedside chart should show all of these on a single 24 h view. The pediatric stroke unit / PICU rounds twice daily.


6. What is normal? Age-banded reference for the monitors in question

AgeTCD MCA MFV (cm/s)NIRS rSO2 (% awake)NPi
6 mo74 ± 1470 to 803.0 to 4.5
1 to 3 y85 ± 1070 to 803.5 to 4.7
4 to 6 y97 ± 965 to 803.5 to 4.7
7 to 11 y89 ± 965 to 803.5 to 4.8
12 to 18 y75 ± 1360 to 803.5 to 4.7
In children

Stroke-affected hemisphere asymmetry is the key abnormal pattern. A 30% asymmetry in MCA MFV, a 10 to 15% asymmetry in NIRS rSO2, or a 30% asymmetry in cEEG amplitude all warrant urgent investigation. The absolute number on the affected side is less informative than the side-to-side difference.


7. What is abnormal? Pattern library

Fig. 2
PERI-STROKE MNM PATTERN LIBRARYfive peri-stroke patterns; TCD MFV and NIRS rSO2 are the continuous bedside signals(a) Acute occlusioncontraMFVMFVlow / absentrSO250 to 60%cEEGslowedlow amplitude(b) Post-recanalisation hyperperfusioncontraMFVMFV+30 to 50%vs contralateralrSO280 to 90%overshootBP needs lowering.(c) Re-occlusioncontraMFVMFVabrupt droprSO2fallingexam may not deteriorate yet.(d) Malignant oedemadays 2 to 5CT axialNPifallingONSDrisingCTmidline shiftipsilateral mass effect.(e) Hyperperfusion bleedCT axialNIRSsudden riseexamnew deficitCTbleed in infarctMNM-Edu schematic · signal trends are schematic, not live data
Five peri-stroke MNM patterns. (a) Acute occlusion: ipsilateral MFV low or absent, NIRS rSO2 50 to 60%, cEEG slowed and reduced amplitude. (b) Post-recanalisation hyperperfusion: ipsilateral MFV rises 30 to 50% above contralateral, NIRS rSO2 overshoots to 80 to 90%, BP needs lowering. (c) Re-occlusion: ipsilateral MFV abruptly drops, NIRS rSO2 falls, exam may not deteriorate yet. (d) Malignant oedema (days 2 to 5): ipsilateral mass effect, falling NPi, rising ONSD, midline shift on CT. (e) Hyperperfusion bleed: sudden NIRS rise + new neurological deterioration + CT shows bleed in infarct territory.
MNM-Edu, original schematic.
PatternBedside signatureAction
Acute occlusionLow MFV, low rSO2, cEEG slowingIV-tPA / MT decision
Post-recanalisation hyperperfusionMFV up 30%, rSO2 overshootLower MAP 10 to 15% gently
Re-occlusionAbrupt MFV drop, rSO2 fallsUrgent imaging, consider reintervention
Malignant oedemaFalling NPi, rising ONSD, midline shiftHyperosmolar; consider decompressive craniectomy
Hyperperfusion bleedrSO2 overshoot + exam deteriorationUrgent CT; reverse anticoagulation if applicable
New seizure burdencEEG shows seizuresAnticonvulsant escalation
Vasospasm-like riseMFV rises bilaterallyVerify with Lindegaard; usually not vasospasm in pediatric AIS

Decision tree: peri-recanalisation monitoring


8. Try it: interactive widgets

LindegaardCalculator
Loading widget…

9. Management decisions in pediatric AIS

9.1 Acute hyperacute window

  1. Activate the stroke pathway: door-to-imaging within 60 minutes per AHA pediatric stroke guidelines.
  2. Imaging: MRI + MRA preferred; CT + CT angio acceptable.
  3. Confirm AIS and exclude haemorrhage / mimic.
  4. Candidacy assessment for IV-tPA (NIHSS ≥ 6, within 4.5 h of last seen well, no haemorrhage on imaging, no contraindication).
  5. Candidacy assessment for MT (proximal large-vessel occlusion, favourable imaging, age and centre considerations).
  6. Multidisciplinary decision (pediatric neurology, pediatric stroke team, interventional radiology, PICU, family input).

9.2 Peri-intervention monitoring

  1. Arterial line for continuous BP.
  2. Bedside TCD over both MCAs (or contralateral MCA as reference).
  3. Bilateral NIRS pads.
  4. cEEG initiated for the post-procedure 24 to 48 h.
  5. Continuous pulse oximetry, capnography, temperature as standard.

9.3 Post-recanalisation BP management

The risk of hyperperfusion bleed peaks in the first 24 h post-recanalisation. AHA pediatric stroke guidelines suggest MAP targets in the lower half of the age-appropriate range after successful recanalisation. Bedside NIRS rSO2 overshoot (> 15% above pre-procedure or > 20% asymmetric) prompts gentle MAP lowering (10 to 15%) with esmolol or labetalol.

9.4 Anticoagulation / antiplatelet for secondary prevention

Cardio-embolic AIS: anticoagulation (LMWH or warfarin) typically started after 24 to 72 h, depending on infarct size and bleed risk. Arteriopathic AIS: antiplatelet (aspirin 1 to 5 mg/kg/day) usually started after 24 h. Multidisciplinary discussion with pediatric haematology.

9.5 Malignant oedema and decompressive craniectomy

Large MCA infarct with midline shift > 5 mm, falling NPi, expanding ONSD, and deteriorating exam: decompressive hemicraniectomy reduces mortality in adult MCA infarct and is increasingly used in pediatric MCA infarct in selected centres. Timing is the operative decision: too early may be unnecessary, too late may be futile.

9.6 Sickle cell disease (STOP-screening protocol)

Annual TCD TAMMV screening in children with HbSS or HbSβ-thalassemia, ages 2 to 16 years. TAMMV ≥ 200 cm/s = abnormal, chronic monthly transfusion initiated (STOP-1 / STOP-2). TAMMV 170 to 199 = conditional, re-screen sooner. TAMMV < 170 = normal, annual repeat.

9.7 Moyamoya progression monitoring

Serial TCD detects progression of terminal ICA stenosis: rising MCA MFV in the absence of vasospasm + clinical context of known moyamoya disease. Combined with serial MRA, drives the decision about surgical revascularisation (encephalo-duro-arterio-synangiosis or related).

Caveat

Teaching, not protocol. Pediatric stroke management is a multidisciplinary, centre-experience-dependent activity. Every threshold (MAP target, NIRS asymmetry, NPi cut-off) is age-specific and patient-specific. Defer to your pediatric stroke service and PICU clinical team for decisions; the MNM signals on this page are cueing tools, not treatment protocols.

Educational algorithm, not a clinical protocol. This walkthrough is a teaching aid. Defer to your unit's pediatric protocols, current PBTF / Kochanek / local guidelines, and your senior clinical team. Doses, thresholds, and decision points are starting points, not prescriptions.

10. Clinical contexts: stroke MNM in different scenarios

10.1 Pediatric AIS in school-age children

The classic 8 to 12 year old with sudden-onset hemiparesis. Bedside MNM during peri-intervention and the first 48 h post-recanalisation: TCD, NIRS, cEEG, NPi. Decompressive craniectomy if malignant oedema. The TIPS study and 2019 AHA pediatric stroke guidelines provide the framework.

10.2 Pediatric AIS in toddlers and infants

Diagnosis is harder (focal signs are subtle, exam-difficult), so MNM (asymmetric NIRS, asymmetric aEEG / cEEG) often raises the first alarm in a sedated post-cardiac-surgery infant or a neonate. Decision-making about thrombolysis in this age group is largely centre-experience-dependent; thrombectomy is rare under age 2.

10.3 Cerebral sinovenous thrombosis (CSVT)

Different physiology (venous outflow obstruction) and different management (anticoagulation, hydration, raised ICP support). MNM role: cEEG for seizures (common in CSVT), ONSD for raised ICP, NIRS for tissue oxygenation. Imaging-driven decisions (MR venography + diffusion).

10.4 Stroke in sickle cell disease

The STOP screening pathway is the central preventive intervention. Acute SCD AIS: emergent transfusion exchange to HbS < 30%; multidisciplinary management with paediatric haematology, neurology, and PICU. MNM during the acute window adds NIRS, cEEG, NPi.

10.5 Stroke complicating congenital heart disease

Post-op cardiac patients have stroke rates of 3 to 10%. Bedside MNM (especially asymmetric NIRS) is the early warning. The Norwood, arterial switch, and Glenn / Fontan patients are highest risk.

10.6 Stroke during pediatric ECMO

VA-ECMO has 5 to 15% acute stroke risk. The ELSO neurological surveillance bundle includes daily NIRS, NPi, and selective neuroimaging. Continuous TCD is informative but technically harder on the non-pulsatile ECMO patient.

10.7 Stroke after meningitis or encephalitis

Bacterial meningitis (especially pneumococcal) can cause vasculitic stroke. Herpes simplex encephalitis classically affects temporal lobes and causes focal seizures and stroke. MNM role: cEEG (seizures), ONSD (oedema), NIRS (tissue oxygenation).

10.8 Stroke as a complication of trauma (dissection)

Cervical artery dissection from blunt or twisting neck trauma can cause AIS hours to days later. The dissection itself may not be obvious on initial CT. MNM role: clinical surveillance, cEEG if obtundation develops, surgical / endovascular decisions through neurosurgery and interventional radiology.

10.9 Stroke after cardiac arrest (anoxic, embolic, or both)

Post-arrest patients can have both diffuse HIE injury and focal embolic stroke. MNM role: cEEG and aEEG for seizures, NIRS for asymmetric desaturation that might indicate focal stroke on top of HIE, NPi for brainstem function. Multimodal prognostication framework applies.


11. Multimodal integration: stroke MNM stack

Pair with…What you gainWorked scenario
Clinical exam (PedNIHSS)The diagnostic gateTrend serial PedNIHSS during 48 h post-recanalisation
TCDReocclusion, hyperperfusion, embolic monitoringContinuous TCD shows abrupt MFV drop on re-occlusion
NIRSTissue oxygenation asymmetryAsymmetric rSO2 in sedated infant raises stroke alarm
cEEG / qEEGHemispheric asymmetry, seizure burdenSubclinical seizures in 5 to 15% of pediatric AIS
NPiMalignant oedema early-warningFalling NPi pre-decompressive-craniectomy decision
ONSDSurrogate ICP for malignant oedemaRising ONSD over 24 h supports decompression
Imaging (MRI, CT, angio)Diagnostic gold standardAcute MRI + MRA at presentation
NPi + cEEG + NIRS + TCDComposite peri-recanalisation MNMThe integrated bedside view

12. Setup and technique

12.1 Imaging pathway

  1. Activate the pediatric stroke pathway at any sudden focal deficit, dysarthria, or focal seizure with persistent deficit.
  2. First imaging: MRI with diffusion + MRA preferred. CT with CT angio acceptable when MRI is delayed.
  3. Hyperacute decision about IV-tPA and MT candidacy in a multidisciplinary huddle including pediatric neurology, PICU, interventional radiology, anaesthesia, family.
  4. Repeat imaging at 24 h to assess infarct evolution and rule out haemorrhagic transformation.

12.2 MNM bundle at the bedside

  1. Arterial line for continuous BP and arterial sampling.
  2. Bilateral NIRS pads (frontal cortex) placed at admission; trend baseline asymmetry.
  3. cEEG initiated as soon as practical; full 10-20 montage if available, reduced montage if not.
  4. TCD baseline scan: bilateral MCA, ACA, PCA; document MFV, PI on both sides. Continuous (fixed headframe) if available and recanalisation is planned.
  5. Pupillometer (NPi) at admission and Q4 hourly during the surveillance window.
  6. ONSD at admission and Q12 to Q24 hourly during the malignant-oedema window.
  7. Document all MNM values on a unified bedside chart with PedNIHSS, MAP, glucose, temperature.

12.3 Peri-intervention setup

  1. Anaesthesia consult for thrombectomy logistics.
  2. Continuous TCD during MT: monitor for re-occlusion, hyperperfusion, embolic signals.
  3. NIRS continuous: any asymmetry > 15% during the procedure flagged to the team.
  4. Post-procedure: bedside MNM for 48 h minimum; longer if any concern.

12.4 Decompressive craniectomy decision

The bedside MNM signals that support decompression:

  • Midline shift > 5 mm on CT.
  • Falling NPi, especially with asymmetry > 0.7.
  • Expanding ONSD above age-banded cut-off.
  • Falling GCS or PedNIHSS deterioration.
  • Failure to respond to maximal medical therapy (hyperosmolar, sedation, normothermia).

The decision is multidisciplinary (neurosurgery, PICU, neurology, family) and centre-experience-dependent. The pediatric outcome data after decompression are evolving but generally favourable when timing is appropriate.

12.5 STOP-protocol TCD in SCD

  1. Annual TCD in HbSS or HbSβ-thalassemia, ages 2 to 16 years.
  2. Non-imaging (blind) TCD or non-angle-corrected TCCD: angle correction systematically over-reads TAMMV.
  3. TAMMV in MCA (and basilar, in some protocols): time-averaged maximum mean velocity.
  4. Interpret per STOP-1 / STOP-2: < 170 normal, 170 to 199 conditional, ≥ 200 abnormal.
  5. Abnormal: confirm with second scan within 6 weeks; if confirmed, initiate chronic monthly transfusion to maintain HbS < 30%.

12.6 Moyamoya monitoring

Serial TCD every 6 to 12 months; pair with serial MRA. Rising MFV in the MCA or new collateral signals indicate progression. Surgical revascularisation (EDAS or related) is the definitive treatment in symptomatic disease.


13. Pitfalls

  • Delayed recognition of pediatric stroke: the median time from symptom onset to diagnosis is 24 hours; high index of suspicion is the first step.
  • Stroke mimics: post-ictal Todd's paresis, complex migraine, conversion disorder; imaging is the differentiator.
  • Adult MFV thresholds in children would miss vasospasm or over-call hyperperfusion; use age-banded reference.
  • STOP TAMMV with angle-corrected TCCD: angle correction over-reads; use non-angle-corrected for STOP screening.
  • Single-modality decisions: never decide on decompressive craniectomy or IV-tPA on one MNM signal alone; multimodal + clinical + imaging concordance.
  • Hyperperfusion bleed: the rSO2 overshoot is the warning; lower MAP gently, not aggressively.
  • Cardio-embolic stroke missed in sedated post-cardiac-surgery infants: asymmetric NIRS and aEEG are often the only early markers.
  • CSVT diagnosed late: presentation is non-specific; MR venography is the gold standard.
  • Pediatric thrombectomy evidence is C-level: outcomes appear favourable but RCT data are limited; centre experience matters.
  • Moyamoya progression is silent: serial TCD between annual visits catches it.

14. Combine with…

  • TCD: the central modality for peri-intervention monitoring and STOP screening.
  • NIRS: bilateral asymmetry as the early stroke signal.
  • qEEG / cEEG: seizure surveillance and hemispheric asymmetry.
  • Pupillometry: malignant oedema early warning.
  • ONSD: bedside ICP surrogate for oedema progression.
  • Clinical exam: the diagnostic gate; PedNIHSS is the structured exam tool.
  • Foundations: autoregulation: the physiology behind post-recanalisation hyperperfusion.

15. Evidence summary

TopicSourceGrade
AHA / ASA pediatric stroke guidelinesexpert
TIPS studyC
Pediatric thrombectomy reviewC
Pediatric TCD primer expert
STOP trial (SCD)A
STOP-2 trialA
Pediatric MFV reference data B/C
Pediatric NIRS reference C
ACNS pediatric cEEGexpert
Neonatal cEEG / aEEG expert
Pediatric MMM review (Laws 2022)review
Pediatric post-arrest brain injuryreview
ELSO neurological guidelinesexpert
Pediatric BTF (TBI)expert

16. Recent literature (2022 to 2025)

  • Sun 2020 pediatric thrombectomy review: summarises small series suggesting favourable recanalisation rates and functional outcomes in selected children with large-vessel occlusion.
  • LaRovere 2015 pediatric TCD review: applications of TCD in paediatric neurocritical care, including stroke monitoring.
  • Slovis 2024 pediatric post-arrest brain injury: framework that overlaps with peri-stroke MNM (multimodal prognostication, NPi, cEEG).
  • Laws 2022 pediatric MMM review: stroke and brain-injury MNM as a single overlapping framework.
  • Laws 2022 pediatric MMM review: stroke as a pediatric neurocritical care entity with overlapping MNM strategy.

17. Self-check

Retrieval check
An 8-year-old with left M1 occlusion undergoes mechanical thrombectomy with TICI 2b at 4.5 h. Immediately post-procedure, bedside NIRS over the left hemisphere rises from 52% to 78% over minutes; right NIRS stable at 68%. The PedNIHSS is improving. Most appropriate next step?
A 12-year-old with HbSS sickle cell disease undergoes annual STOP-protocol TCD. The technician reports TAMMV 215 cm/s in the right MCA using a TCCD device with angle correction enabled. Patient is asymptomatic. Best interpretation and action?
An 18-month-old on day 3 after a complex Norwood stage 1. Bilateral NIRS pads show right rSO2 trending 68% → 51% over 6 h while left remains 67%. aEEG shows new asymmetry: right amplitude 30% lower. Clinical exam reads sedated but pupils symmetric. Best next step?

References

  1. Ferriero DM, Fullerton HJ, Bernard TJ, et al.. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke 2019;50(3):e51-e96. doi:10.1161/STR.0000000000000183 link
  2. Sun LR, Harrar D, Drocton G, et al.. Mechanical Thrombectomy for Acute Ischemic Stroke. Stroke 2020;51(10):3174-3181. doi:10.1161/STROKEAHA.120.029698 link
  3. Poletto E, Kanthimathinathan HK, Gyorgyi Z. How to perform and interpret a middle cerebral artery transcranial Doppler examination in children at risk of brain injury. Archives of Disease in Childhood - Education and Practice 2024;109(2):98-104. doi:10.1136/archdischild-2023-325747 link
  4. Adams RJ, McKie VC, Hsu L, et al.. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. NEJM 1998;339(1):5–11. doi:10.1056/NEJM199807023390102 link
  5. Adams RJ, Brambilla D, STOP-2 Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. NEJM 2005;353(26):2769–2778. doi:10.1056/NEJMoa050460 link
  6. Rivkin MJ, deVeber G, Ichord RN, et al.. Thrombolysis in pediatric stroke study (TIPS). Stroke 2015;46(3):880–885. doi:10.1161/STROKEAHA.114.008210 link
  7. Davies DJ, Su Z, Clancy MT, et al.. Near-infrared spectroscopy in the monitoring of adult traumatic brain injury: a review. Journal of Neurotrauma 2015;32(13):933-941. doi:10.1089/neu.2014.3748 link
  8. Andresen B, Greisen G, Hyttel-Sorensen S. Comparison of INVOS 5100C and Nonin SenSmart X-100 oximeter performance in preterm infants with spontaneous apnea. Pediatric Research 2020;87(7):1244-1250. doi:10.1038/s41390-020-0752-6 link
  9. Herman ST, Abend NS, Bleck TP, et al.. Consensus statement on continuous EEG in critically ill adults and children, part I and II (ACNS). Journal of Clinical Neurophysiology 2015;32(2-3):87-105 / 96-108. doi:10.1097/WNP.0000000000000165 link
  10. Sansevere AJ, Kapur K, Peters JM, et al.. Seizure Prediction Models in the Neonatal Intensive Care Unit. Journal of Clinical Neurophysiology 2019;36(3):186–194. doi:10.1097/WNP.0000000000000574 link
  11. Oddo M, Taccone FS, Petrosino M, et al. (ORANGE Investigators). The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study. Lancet Neurology 2023;22(10):925–933. doi:10.1016/S1474-4422(23)00271-5 link
  12. Padayachy LC, Padayachy V, Galal U, Pollock T, Fieggen AG. The relationship between transorbital ultrasound measurement of the optic nerve sheath diameter (ONSD) and invasively measured ICP in children. Childs Nervous System 2016;32(10):1769-1778. doi:10.1007/s00381-016-3067-5 link
  13. Bode H. Pediatric Applications of Transcranial Doppler Sonography. Springer-Verlag 1988. doi:10.1007/978-3-7091-8985-6 link
  14. O'Brien NF. Reference values for cerebral blood flow velocities in critically ill, sedated children. Child's Nervous System 2015;31(12):2269–2276. doi:10.1007/s00381-015-2873-5 link
  15. LaRovere KL, O'Brien NF. Transcranial Doppler sonography in pediatric neurocritical care. Journal of Ultrasound in Medicine 2015;34(12):2121-2132. doi:10.7863/ultra.15.02016 link
  16. Freeman AD, McCracken CE, Stockwell JA. Automated Pupillary Measurements Inversely Correlate With Increased Intracranial Pressure in Pediatric Patients With Acute Brain Injury or Encephalopathy. Pediatric Critical Care Medicine 2020;21(8):753-759. doi:10.1097/PCC.0000000000002327 link
  17. Slovis JC, Bach A, Beaulieu F, et al.. Neuromonitoring after Pediatric Cardiac Arrest: Cerebral Physiology and Injury Stratification. Neurocritical Care 2024;40(1):99-115. doi:10.1007/s12028-023-01685-6 link
  18. Lorusso R, Taccone FS, Belliato M, et al.. Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments. Minerva Anestesiologica 2017;83(10):1061-1074. doi:10.23736/s0375-9393.17.11911-5 link
  19. Pisano DV, Ortoleva JP, Wieruszewski PM. Short-Term Neurologic Complications in Patients Undergoing Extracorporeal Membrane Oxygenation Support: A Review on Pathophysiology, Incidence, Risk Factors, and Outcomes. Pulmonary Therapy 2024. doi:10.1007/s41030-024-00265-z link
  20. Tunkel AR, Glaser CA, Bloch KC, et al.. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2008;47(3):303-327. doi:10.1086/589747 link
  21. van de Beek D, Cabellos C, Dzupova O, et al.. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clinical Microbiology and Infection 2016;22 Suppl 3:S37-S62. doi:10.1016/j.cmi.2016.01.007 link
  22. Kochanek PM, Tasker RC, Carney N, et al.. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary. Pediatric Critical Care Medicine 2019;20(3S):S1-S82. doi:10.1097/PCC.0000000000001736 link
  23. Topjian AA, Scholefield BR, Pinto NP, et al.. Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association. Circulation 2019;140(6):e194-e233. doi:10.1161/CIR.0000000000000697 link
  24. Laws JC, Jordan LC, Pagano LM, Wellons JC, Wolf MS. Multimodal Neurologic Monitoring in Children With Acute Brain Injury. Pediatric Neurology 2022;129:62-71. doi:10.1016/j.pediatrneurol.2022.01.006 link
  25. Pressler RM, Cilio MR, Mizrahi EM, et al.. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia 2021;62(3):615-628. doi:10.1111/epi.16815 link